pharmaceutical investing

Australia’s healthcare and biotechnology sector has matured into one of the most promising and strategically…
Read More...

InMed Pharmaceuticals (NASDAQ: INM) pairs innovative therapeutic development in Alzheimer’s, ophthalmology, and…
Read More...

Invion’s (ASX:IVX,OTC Pink:IVIXF) Photosoft cancer treatment technology has entered an important milestone, thanks to…
Read More...

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a…
Read More...

Investor Insight Cardiol Therapeutics is positioned…
Read More...

The gold price cooled off this week as tariff-related uncertainty reached a resolution.The yellow metal was thrust…
Read More...

Today's pharmaceutical stocks are facing the challenges of government-imposed drug price caps, waning demand for…
Read More...

The second quarter of 2025 was a period of dynamic evolution within the biotech and pharma sectors. Critical factors…
Read More...

The approvals are supported by results of the pivotal Phase 3 SELECT-GCA clinical trial, which met the primary…
Read More...

Big pharma ETFs To help investors learn more about…
Read More...